前阿里CEO卫哲入局圣湘生物,传统检测厂商变身“科技成长股”?

创业最前线
Sep 24, 2025

出品 | 创业最前线作者 | 张珏编辑 | 蛋总美编 | 邢静审核 | 颂文疫情检测红利消退后,体外诊断(IVD)行业近两年一直处在漫长的调整期,不断有企业被淘汰出清。在这之中,圣湘生物的2025年半年报显得格外独特:公司营收8.69亿元,同比增长21.15%,归母净利润1.63亿元,同比增长3.84%,与一众亏损或萎缩的同行形成反差。事实上,近两年的圣湘生物,并未幸免于这场行业下行的冲击:...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10